ZC4H2
protein-codingzinc finger C4H2-type containing, the group of Zinc fingers
Gene summary
This gene encodes a member of the zinc finger domain-containing protein family. This family member has a C-terminal zinc finger domain that is characterized by four cysteine residues and two histidine residues, and it also includes a coiled-coil region. This protein has been detected as an autoantigen in hepatocellular carcinoma patients. This gene has been identified as a potential candidate for X-linked cognitive disability. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2011]
- KIAA1166
- WWS
- MCS
- MRXS4
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~118.9 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: XL
Disease ID:MONDO:0010758
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: XL
Disease ID:MONDO:0026762
Submitter: G2P
Inheritance Pattern: XL
Disease ID:MONDO:0020119
Submitter: ClinGen
*ZC4H2* was first reported in relation to X-linked syndromic intellectual disability in 2013 (Hirata et al., PMID: 23623388). *ZC4H2*-associated disorders include Wieacker-Wolff syndrome and Miles-Carpenter syndrome. Individuals with *ZC4H2* variants present with developmental delay, intellectual disability, arthrogryposis multiplex congenita, hypo-/akinesia, facial dysmorphism, and skeletal abnormalities (Frints et al., 2019, PMID: 31206972). Variants in this gene have been reported in at least 33 probands in 3 publications (PMIDs: 23623388, 26056227, 31206972). More evidence is available in the literature, but the maximum score for genetic evidence (12 points) has been reached. Variants in affected males are mostly inherited missense and are likely hypomorphic alleles, whereas female patients have *de novo* loss-of-function variants, which are likely lethal in males (PMID: 31206972). The mechanism of pathogenicity is loss of function. This gene-disease relationship is also supported by phenotype characterization and rescue experiments in a zebrafish model. In summary, there is definitive evidence supporting the relationship between *ZC4H2* and X-linked syndromic intellectual disability. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. This classification was approved by the ClinGen Intellectual Disability and Autism Gene Curation Expert Panel on October 7, 2020 (SOP Version 7).
Inheritance Pattern: XL
Disease ID:MONDO:0026762
Submitter: Ambry Genetics
Inheritance Pattern: XL
Disease ID:MONDO:0010758
Submitter: PanelApp Australia
Inheritance Pattern: XL
Disease ID:MONDO:0010758
Submitter: Orphanet
Inheritance Pattern: XL
Disease ID:MONDO:0010758
Submitter: Ambry Genetics
Clinical Genomic Database (CGD)
Manifestation: Craniofacial; Genitourinary; Musculoskeletal; Neurologic
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to ZC4H2 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_018684.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 2 | 6 | 34 | 4 | 46 | |
| missense | 9 | 17 | 92 | 6 | 2 | 126 |
| nonsense | 7 | 5 | 2 | 14 | ||
| start loss | 1 | 1 | 2 | |||
| frameshift | 9 | 8 | 2 | 19 | ||
| splice donor/acceptor (+/-2bp) | 3 | 4 | 3 | 10 | ||
| Total | 29 | 36 | 106 | 40 | 6 | 217 |
Highest pathogenic variant AF is 0.000008934714
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_061154.1 | 5 | MANE Select | |
| Ensembl | ENSP00000363972.3 | 5 | MANE Select | |
| RefSeq | NP_001171503.1 | 4 | Standard | |
| RefSeq | NP_001171504.1 | 4 | Standard |
Model Organisms & Knockout Phenotypes
Observed phenotypic effects in mouse and zebrafish models
| Gene / Model | Organism | Observed Phenotype |
|---|---|---|
| zc4h2 | Danio rerio | Structure: motor neuron Quality: disorganized abnormal |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Biological Process
- nervous system development
- neuromuscular junction development
- spinal cord motor neuron differentiation
- positive regulation of neuron differentiation
Molecular Function
- protein binding
- metal ion binding
Cellular Component
- nucleus
- cytoplasm
- cell junction
- postsynaptic membrane
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000374839
- Coding exons
- 5
- Length
- 118344
- Individuals with no LoFs
- 0
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 0
- Defined
- 0
- p
- 0.00
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 1.51 | 47 | 86.6 | 0.543 | 0.00000694 | 1487 |
| Missense (PolyPhen) | 10 | 30.128 | 0.33192 | 481 | ||
| Synonymous | -1.42 | 43 | 32.7 | 1.32 | 0.00000251 | 405 |
| Loss of Function | 2.57 | 0 | 7.68 | 0.00 | 5.54e-7 | 139 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0 | 0.0 | absent |
| Latino/Admixed American | 0 | 0.0 | absent |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0 | 0.0 | absent |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0 | 0.0 | absent |
| South Asian | 0 | 0.0 | absent |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Plays a role in interneurons differentiation (PubMed:26056227). Involved in neuronal development and in neuromuscular junction formation. {ECO:0000269|PubMed:23623388, ECO:0000269|PubMed:26056227}.;
Recessive Scores
- pRec
- 0.113
Intolerance Scores
- LoFtool
- 0.0870
- RVIS EVS
- -0.03
- RVIS percentile EVS
- 51.4
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.801
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |